RxDoctor Payments Data

Emily Young

Medical · Oxnard, CANPI 1194067181

Payments from drug & device makers

$8,670in general payments, 2019–2025

Across 345 payments — averaging $25.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$993
  • AstraZeneca$671
  • Novartis$620
  • AbbVie$579
  • Johnson & Johnson$405
  • Merck$375
  • plus $5K from 46 others

What the payments were for

  • Food & beverage$7,88091%
  • Education$7909%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,670 in reported general payments places this provider in the 90th percentile of 2,087 medical providers in California.

See all medical providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dexamethasone14$408
Anastrozole21$271
Ondansetron OdtOndansetron20$230
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen13$212
Prednisone17$55

Paid to pharmacies, not to this prescriber.

Other medical in Oxnard

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →